General Information
Version
6.7
Revision date
2023-11-27
Product name
Pd(0) EnCat 30NP
REACH No
This
1.2.2. Uses advised against
For R&D use only. Not for pharmaceutical, household or other uses
Emergency telephone
+33 (0)9 75 18 14 07, +33 (0)1 45 42 59 59
Icons in SDS
Company Information
company name
Merck Life Science S.A.S
e-mail address of the competent person responsible for the Safety Data Sheet
servicetechnique@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H251
Hazard statements
Code
Statements
H251
Self-heating; may catch fire
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H251 Self-heating; may catch fire.
Precautionary statements
P235 Keep cool. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P403 + P235 Store in a well-ventilated place. Keep cool. P407 Maintain air gap between stacks or pallets. P420 Store separately.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Self-heating substances and mixtures (Category 1), H251 For the full text of the H-Statements mentioned in this Section, see Section 16.
